Boston Scientific Corporation
MX ˙ BMV ˙ FR0010424135
SecurityMX:BSX / Boston Scientific Corporation
InstitutionArkadios Wealth Advisors
Latest Disclosed Ownership46,610 shares
Latest Disclosed Value $ 2,924,781
Arkadios Wealth Advisors reports 4.13% increase in ownership of BSX / Boston Scientific Corporation

On May 18, 2026 - Arkadios Wealth Advisors filed a 13F-HR form disclosing ownership of 46,610 shares of Boston Scientific Corporation (MX:BSX) valued at $2,924,781 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 44,760 shares of Boston Scientific Corporation. This represents a change in shares of 4.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 46,610 1,850 4.13 2,925 -31.47 0.0308
2026-02-13 2025-12-31 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 44,760 7,024 18.61 4,268 15.83 0.0827
2025-10-29 2025-09-30 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 37,736 16,996 81.95 3,684 65.42 0.0884
2025-08-04 2025-06-30 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 20,740 1,606 8.39 2,228 15.39 0.0657
2025-05-08 2025-03-31 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 19,134 19,134 1,930 0.0729
2022-02-03 2021-12-31 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 0 -356 -100.00 0 0.0000
2021-10-19 2021-09-30 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 356 0 0.00 0 0.0022
2021-07-28 2021-06-30 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 356 0 0.00 0 0.0018
2021-04-26 2021-03-31 13F BOSTON SCIENTIFIC CORP COM Stock 101137107 356 356 0 0.0021
2020-11-10 2020-09-30 13F BOSTON SCIENTIFIC CORP COM Common Stock 101137107 0 -49 -100.00 0 -100.00
2020-08-10 2020-06-30 13F BOSTON SCIENTIFIC CORP COM Common Stock 101137107 49 25 104.17 2 120.31 0.0010
2020-05-14 2020-03-31 13F BOSTON SCIENTIFIC CORP COM Common Stock 101137107 24 24 1 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.